Skip to main content
. 2018 Jun 26;62(7):e00011-18. doi: 10.1128/AAC.00011-18

TABLE 4.

Adverse effects associated with amikacin inhalation-containing regimens

Adverse effect No. (%) of patients with:
Discontinuation Regimen changea Total
Total 21 (27) 8 (10) 29 (38)
Ototoxicity 11 (14) 4 (6) 15 (19)
Fatigue 6 (8) 1 (1) 7 (9)
Tinnitus 3 (4) 1 (1) 4 (5)
Cough 1 (1) 1 (1) 2 (3)
Hoarseness 0 1 (1) 1 (1)
Nephrotoxicity 0 0 0
a

Change of amikacin inhalation from 500 mg once daily to 500 mg three times weekly.